Ironwood Pharmaceuticals (IRWD) Retained Earnings (2010 - 2026)
Ironwood Pharmaceuticals (IRWD) posted Retained Earnings of -$1.6 billion for Q1 2026, down 153951.42% sequentially from -$1.1 million in Q4 2025, and down 555523.47% YoY from N/an in Q1 2025.
Ironwood Pharmaceuticals (IRWD) Retained Earnings (2010 - 2026) Analysis & Trends
Ironwood Pharmaceuticals has reported Retained Earnings for 17 years, with the latest figure at -$1.6 billion in Q1 2026.
- Quarterly Retained Earnings fell 555523.47% year-over-year to -$1.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.6 billion (down 555523.47% YoY) and the FY2025 annual result came in at -$1.1 million, up 99.94% from the prior year.
- Retained Earnings slipped to -$1.6 billion in Q1 2026 per IRWD's latest filing, from -$1.1 million in the prior quarter.
- Over five years, Retained Earnings peaked at $294000.0 in Q1 2025 and troughed at -$1.7 billion in Q2 2023.
- A 5-year average of -$614.4 million and a median of -$650.7 million in 2023 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2025 and 2026: Retained Earnings jumped 131.89% in 2025, then sank 555523.47% in 2026.
- Over 5 years, Retained Earnings stood at -$696.4 million in 2022, then soared by 99.56% to -$3.0 million in 2023, then sank by 55912.37% to -$1.7 billion in 2024, then jumped by 99.94% to -$1.1 million in 2025, then plunged by 153951.42% to -$1.6 billion in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$1.6 billion, -$1.1 million, and -$1.7 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 3.75 Bn |
| 10 | Ironwood Pharmaceuticals | 669.13 Mn | 590.00 Mn | - | -1.58 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.58 Bn |
| Mar 31, 2026 | -1.63 Bn |
| Dec 31, 2025 | -1.06 Mn |
| Sep 30, 2025 | -1.67 Bn |
| Jun 30, 2025 | -2.03 Mn |
| Mar 31, 2025 | 294,000.00 |
| Dec 31, 2024 | -1.70 Bn |
| Sep 30, 2024 | -2.05 Mn |
| Jun 30, 2024 | -470,000.00 |
| Mar 31, 2024 | -922,000.00 |
| Dec 31, 2023 | -3.03 Mn |
| Sep 30, 2023 | -752,000.00 |
| Jun 30, 2023 | -1.71 Bn |
| Mar 31, 2023 | -650.66 Mn |
| Dec 31, 2022 | -696.38 Mn |
| Sep 30, 2022 | -745.24 Mn |
| Jun 30, 2022 | -795.56 Mn |
| Mar 31, 2022 | -832.64 Mn |
| Dec 31, 2021 | -937.61 Mn |
| Sep 30, 2021 | -978.98 Mn |